3rd Quarter Consolidated Financial Results for the Year Ending March 31, 2019 
（127.0K）
Presentation for 3rd Quarter Consolidated Financial Results for the Year Ending March 31, 2019 （375.9K）
Daicel Successfully Defends Itself in Patent Infringement Litigation
Daicel Developed Pyro-drive Jet Injector “Actranza™ lab.”for Intracellular Drug Delivery in the Laboratory
President’s Message on Dr. Yoshio Okamoto’s Receipt of “2019 Japan Prize”
Acquisition of U.S. Genomics Company: Arbor Biosciences
Recovery and Operating Situation of Peracetic Acid Plant at Ohtake Plant (Fire at Ohtake Plant: 6th Report [Final])
Invention Encouragement Prize, FY2018 Kinki Local Commendation for Invention
Establishment of Optical Products Development and Sales Company in Taiwan
Foundation of Automobile Airbag Inflator Sales Company in India
Notice regarding 100% share acquisition of LOMA Holding GmbH, a German pharmaceutical contract development and manufacturing organization
Recognized as “2018 Certified Health & Productivity Management Outstanding Organization ~WHITE 500~”
Sept. 8, 2019
Daicel 100th Anniversary
